A telehealth weight-management service is more than a consultation and a shipment. Someone must review the medical history, decide whether to prescribe, arrange dispensing, explain the product and respond when questions arise. Contour Health describes those responsibilities across its website: an initial Zoom visit, an ongoing relationship with a clinician, medication compounded and filled by Strive Pharmacy, and refills ordered after another discussion. That makes the sequence of care—not simply the advertised weekly price—the most useful way to examine this provider.
This review examines public documentation consulted October 19, 2026. Contour Health offers compounded injectable semaglutide and tirzepatide and advertises free consultations, included follow-up and no weight-loss subscription. Those are meaningful service features, but several details need confirmation before payment: conflicting semaglutide starting prices, different descriptions of vial duration, an age-policy discrepancy and general subscription language that should not be confused with the weight program. The discussion below separates the company's stated responsibilities from pharmacy functions and independent clinical context.
At a glance
- Consultation
- The initial consultation is by Zoom with a licensed clinician, who reviews health history and goals and decides whether prescribing is appropriate.Sources: [7]
- Dispensing
- Contour Health says Strive Pharmacy compounds and fills prescriptions; Contour describes itself as a facilitator, not a pharmacy or manufacturer.
- Follow-up
- The provider advertises text check-ins at least every two weeks, optional video follow-ups and typical clinician replies within about 24 hours on weekdays.Sources: [7]
- Payment
- Weight care is advertised as pay-per-vial, without membership, subscription or automatic refills. Published semaglutide starting figures differ: $25 versus $30 per week.
- Delivery
- The FAQ describes typical home arrival within 3–5 business days after prescribing, without separate timelines for clinical review, preparation and dispatch.Sources: [7]
Start by identifying who is responsible for care
Contour Health's terms identify the website operator as Desert Contour LLC, doing business as Contour Health. The company explicitly says it is not a pharmacy or prescription fulfillment warehouse; its role includes connecting patients with pharmacies that dispense and deliver medication. This distinction matters when a question moves from the consultation to a package, label or payment. A single branded website does not mean one organization performs every step. Our guide to clinicians and telehealth platforms explains that division of responsibilities.
The weight-management page names Melissa Musso, NP, as the clinical lead and Dr. Laarni Gonzales-Naval as medical director. It describes a team of board-certified nurse practitioners handling dosing decisions and check-ins. These are the company's descriptions, not independently verified credentials. A nurse practitioner is a clinician, but should not be described as a physician. Contour also promises to match patients with a clinician licensed in their state and keep them with that same clinician throughout care.
The catalog extends beyond weight management to NAD+, sermorelin and hair-loss treatments involving finasteride and minoxidil. Those programs do not all use the same ordering model. For this review, the central offering is compounded semaglutide or tirzepatide, described on the weight page as once-weekly injections. The broader catalog matters mainly because a general statement about subscriptions or billing may concern a different program rather than the injectable weight service.
The first visit establishes access—not a guaranteed prescription
The initial consultation takes place through Zoom. Contour says a licensed clinician reviews the patient's health history, discusses goals and determines whether a prescription is appropriate. Patients need an internet-connected smartphone, tablet or computer with a camera and microphone, plus the Zoom app. The terms also require a signed telehealth informed-consent agreement before services. Preparing a medication list and questions in advance can make that encounter more useful; our first-consultation preparation guide provides a framework without predicting the prescribing decision.
Contour's FAQ says no particular BMI is required to get started and no laboratory work is required before starting treatment. Those are descriptions of its intake policy, not evidence that everyone qualifies or that testing could never be clinically relevant. The same FAQ says medical necessity and appropriateness are assessed individually. It also says GLP-1s are generally not recommended for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2), or for those who are pregnant or breastfeeding; the clinician reviews the full medical history before prescribing. NIDDK describes medication selection as a discussion encompassing health conditions, other medicines, family history, benefits, adverse effects and costs—not a decision established by a website's entry requirements alone.
Geography and age require separate checks. Contour says it treats patients in 46 states, excluding Michigan, Mississippi, Kentucky and Arkansas; that availability and its licensing claims were not independently verified here. Its FAQ advertises access from age 15, with case-by-case evaluation and parental consent and oversight below 18. Its terms, however, restrict services to people who have reached the legal age of majority where they live. The consulted documentation does not reconcile those statements.
The prescribing decision leads to a separate pharmacy handoff
Contour says it does not manufacture medication. Its homepage identifies Strive Pharmacy as the U.S. 503A compounding pharmacy that compounds and fills prescriptions, and describes Strive as licensed and inspected by its state pharmacy board. The site also makes accreditation and certification claims concerning its pharmacy partner. These remain provider-reported claims in this review, not independent findings about a particular pharmacy location, inspection or dispensing transaction. Patients should know which location will actually fill their prescription.
The homepage says injectables are prepared under United States Pharmacopeia sterile-compounding standards and ship with the supplies needed to use them. That is useful operational information, but it does not replace the dispensed product's label or individualized instructions. FDA has received reports of errors measuring or administering compounded GLP-1 medication, including some associated with hospitalization. Questions about measurement should go to the prescriber or pharmacist, not be resolved by converting a website price or an article into dosing instructions.
Contour also acknowledges that compounded medicines are not FDA approved and that FDA does not review them for safety or effectiveness. FDA recommends compounded drugs when an individual's medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence. Contour's weight page appropriately notes that the trial results it presents concern FDA-approved branded medicines; those results do not establish outcomes for Contour's compounded preparations or an individual patient.
What to settle before authorizing the first vial
The free consultation is also the point where Contour says the exact medication cost will be confirmed before any payment. Its published figures are not fully consistent. The homepage advertises weight care from $120 per month at the starting dose, with dose determining price. The weight-page table lists compounded injectable semaglutide from $30 per week and compounded injectable tirzepatide from $50 per week. A calculator on that same page instead presents semaglutide from $25 per week.
The purchase unit is a vial, not necessarily the week or month used in advertising. One note describes medication as sold in two-month vials; another says a vial typically lasts 6–14 weeks depending on dose. Those descriptions do not establish a universal quantity, total vial price or minimum commitment. Before authorizing payment, the useful comparison is a written quote identifying the prescribed preparation, vial quantity, total charge and expected duration. Our pharmacy-handoff guide offers questions for clarifying the product itself.
| Published description | Condition attached | What remains to confirm |
|---|---|---|
| Weight care from $120/month | Homepage; starting dose only; dose sets price | Which medicine and total vial charge apply |
| Compounded injectable semaglutide from $30/week | Weight-page table; starting price; dose-dependent | Why the calculator shows a different starting figure |
| Compounded injectable semaglutide from $25/week | Calculator on the weight page; starting price | Which quoted price applies to the prescription |
| Compounded injectable tirzepatide from $50/week | Weight-page table; starting price; dose-dependent | Total charge for the selected vial |
| Two-month vials; elsewhere, typically 6–14 weeks | Different descriptions on the same weight page | Quantity and expected duration for the actual order |
Delivery has an advertised window, but not a complete timeline
Contour's FAQ says medication ships directly from its pharmacy partner to the patient's home and typically arrives within 3–5 business days once prescribed. This is an arrival estimate, not merely a dispatch promise, but it starts after prescribing. The documentation does not separately establish appointment availability, clinical-review time, pharmacy preparation time or dispatch time. Someone planning around travel or a refill should therefore ask for the current status of the actual order rather than treating the entire enrollment process as a five-day service.
The homepage says shipping is included in the medication price, and the FAQ advertises no shipping charges. General terms nevertheless allow shipping and handling charges disclosed at purchase, along with applicable taxes. The consulted pages do not explain when those broader clauses would apply. The terms also warn that partner-pharmacy prescriptions may not come in child-resistant containers. Both issues belong in the order conversation: what the final checkout includes, and what packaging and storage responsibilities accompany the delivered product.
A delivery problem also has a clinical dimension. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or inadequately refrigerated, and contacting the provider or dispensing pharmacy to resolve the concern. That advice should not be replaced by reassurance based only on shipment speed. Our guide to warm injectable deliveries explains the distinction. Contour's consulted documentation does not detail refund exceptions or a specific replacement process for damaged, delayed or temperature-compromised shipments.
Follow-up is included, with weekday response boundaries
Contour describes an ongoing relationship rather than a consultation-only transaction. Its FAQ promises text check-ins at least every two weeks, allows patients to reach out more often and says video follow-ups can be requested at any time. The homepage includes clinician time, individualized dosing decisions and check-ins in the medication price. These are meaningful advertised inclusions, although the pages do not establish appointment availability for a requested video visit or a guaranteed response time for every message.
The typical clinician reply window is about 24 hours, Monday through Friday. Contour explicitly says clinicians take weekends off and directs patients with urgent needs to contact the clinic. That wording should not be interpreted as round-the-clock clinical coverage or an emergency service. The published direct clinician texting line is (435) 705-5696. Technical or logistical questions go to office staff by call or text at (435) 414-0360, creating distinct contact routes for care questions and order administration.
The site also provides general education about GLP-1 medications, effects and nutrition, while stating that educational material does not replace medical advice. The practical value of follow-up depends on what happens during those contacts, not simply how often a text arrives. NIDDK describes follow-up as addressing response and tolerability, and medication as accompanying healthy eating and physical activity. Contour's stated continuity with the same clinician could support that work, but the documentation does not independently establish its execution.
Refills require another decision, not an automatic shipment
For weight management, Contour advertises payment by the vial when the patient decides to reorder, with no membership, subscription or automatic refill. Its FAQ describes a specific refill sequence: contact the clinician, review progress and agree on the next vial size based on the current care plan; payment is then processed and the refill ordered. This connects the next purchase to another clinical discussion. It does not establish a guaranteed prescription or a fixed future price.
The distinction from other programs is important. Contour says weight loss, longevity and performance are billed per order, while hair-loss medication uses quarterly automatic refills. Hair tablets are listed at $148 every three months, advertised as $49 per month; the topical option is $189 quarterly, advertised as $63 per month. Each charge supplies three months. Hair care has an initial three-month minimum, then cancellation by email to reception@contourhealthrx.com at least 30 days before the next quarterly charge, without a cancellation fee.
General terms also discuss certain subscriptions with a three-consecutive-month minimum, automatic charging and at least 30 days' cancellation notice after the initial commitment. Those clauses should be distinguished from the explicit no-subscription weight offer, rather than imposed on it without clarification. Separately, the terms state that all purchased products are nonrefundable. Being able to stop future weight orders is therefore not the same as receiving money back for an order already placed; documented exceptions for fulfillment problems were not identified.
Financial responsibility can change at the pharmacy boundary
Contour's terms say it does not participate in Medicare, Medicaid or private health insurance plans, and patients are financially responsible for products and services. That is a statement about this service's payment structure, not a conclusion about every patient's possible insurance benefits elsewhere. HSA/FSA-associated debit and credit cards are accepted, but Contour does not guarantee that an account administrator will approve the expense. Acceptance of a card should not be mistaken for a determination of reimbursement eligibility.
For reimbursement documentation, Contour says it will provide an itemized receipt and that the treating clinician may provide a letter of medical necessity on request. The terms also describe a separate pharmacy pathway: if a prescription is unavailable through partner pharmacies, it can be sent to a pharmacy selected by the patient. In that situation, the patient is responsible for the medication cost and for pickup or arranging delivery. The advertised included-shipping arrangement should not automatically be carried over to that outside-pharmacy scenario.
Questions & answers
Is Contour Health itself the dispensing pharmacy?
No. Its terms describe Contour as a facilitator, not a pharmacy or fulfillment warehouse. The homepage names Strive Pharmacy as the organization that compounds and fills prescriptions. Before ordering, ask which dispensing location will handle the prescription and how to contact it about the label, supplies or shipment.
What will the first semaglutide vial actually cost?
The consulted pages do not establish one universal vial price. The weight table advertises compounded injectable semaglutide from $30 per week, while its calculator shows from $25 per week. Both are starting figures. Contour says the exact dose and cost are confirmed during the free consultation before payment; request the full vial charge, not just its weekly equivalent.
Does weight treatment renew automatically?
Contour explicitly advertises no automatic refills, membership or subscription for weight care. The documented process requires discussing the next vial with the clinician before payment and ordering. Hair-loss treatment has a different quarterly renewal arrangement. Confirm that the checkout terms correspond to weight care, and remember that stopping future orders does not reverse the stated nonrefundability of purchased products.
Can I reach my clinician on weekends?
The published typical response window is about 24 hours on weekdays, and Contour says its clinicians take weekends off. It directs urgent concerns to the clinic, but does not document continuous weekend clinical coverage. The clinician text line is (435) 705-5696; office staff handle technical and logistical matters at (435) 414-0360.
Does the 3–5-business-day estimate start when I sign up?
No. The FAQ describes typical arrival within 3–5 business days once medication is prescribed. It does not separately promise how quickly enrollment, the consultation or clinical review will occur. Ask when the prescription was sent, whether the pharmacy has accepted it and whether a dispatch date is available before relying on an arrival estimate.
Can I use an HSA or FSA card?
Contour accepts cards associated with HSA and FSA accounts, but does not guarantee administrator approval of the expense. It offers an itemized receipt, and a clinician may supply a medical-necessity letter on request. Confirm documentation requirements with the account administrator before purchase rather than treating successful card processing as proof that the expense qualifies.
Our assessment
Contour Health documents a reasonably understandable care pathway: a video assessment, a stated ongoing clinician relationship, pharmacy dispensing, included check-ins and a clinician-mediated refill decision. Its no-subscription weight model is distinct from the recurring hair-loss program and may make future ordering easier to understand. The unresolved details are material, however: inconsistent semaglutide starting prices, conflicting vial-duration descriptions, broad nonrefundability, incomplete shipping-problem procedures and an age-policy discrepancy. Pharmacy and credential claims also remain provider-reported here. Before paying, obtain a written product-and-vial quote, identify the dispensing pharmacy and confirm contact and delivery-problem responsibilities. The documentation supports evaluating Contour as a compounded-injectable telehealth service; it does not establish provider-specific clinical outcomes.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Contour Health — resources/how glp1 medications work ↗
- Contour Health — terms of service ↗
- Contour Health — faqs ↗
- Contour Health — official website ↗
- Contour Health — weight loss ↗